Uptake and metabolism of ciclesonide and retention of desisobutyryl-ciclesonide for up to 24 hours in rabbit nasal mucosa

BMC Pharmacology

Volumn 7, Issue , 2007, Pages

  Sato, Hideyuki ^a   Nave, Ruediger ^b   Nonaka, Takashi ^a   Yoshihisa, Nishibe ^a   Atsuhiro, Nagano ^a   Mochizuki, Tsutomu ^a   Takahama, Shigehiro ^a   Kondo, Shiro ^a   Wingertzahn, Mark ^c  

^a TEIJIN PHARMA LIMITED   (Japan)

^b ALTANA PHARMA AG   (Germany)

^c ALTANA Pharma US   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CICLESONIDE; DESISOBUTYRYL CICLESONIDE; FATTY ACID; NOSE SPRAY; UNCLASSIFIED DRUG; ANTIALLERGIC AGENT; DESISOBUTYRYLCICLESONIDE; ESTER; HYPOTONIC SOLUTION; ISOTONIC SOLUTION; PREGNANE DERIVATIVE;

ALLERGIC RHINITIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG METABOLISM; DRUG RETENTION; DRUG STRUCTURE; DRUG TISSUE LEVEL; DRUG UPTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; NOSE MUCOSA; SINGLE DRUG DOSE; TANDEM MASS SPECTROMETRY; ANIMAL; DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; METABOLISM; RABBIT; SUSPENSION; TIME;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTI-ALLERGIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG ADMINISTRATION SCHEDULE; ESTERS; FATTY ACIDS; HYPOTONIC SOLUTIONS; ISOTONIC SOLUTIONS; MALE; NASAL MUCOSA; PREGNENEDIONES; RABBITS; SUSPENSIONS; TANDEM MASS SPECTROMETRY; TIME FACTORS;

EID: 34447311348     PISSN: None     EISSN: 14712210     Source Type: Journal    
DOI: 10.1186/1471-2210-7-7     Document Type: Article

References (32)

1. Skoner DP Allergic rhinitis: Definition, epidemiology, pathophysiology, detection, and diagnosis J Allergy Clin Immunol 2001 108 1 Suppl S2-S8 11449200
2. Berger WE Overview of allergic rhinitis Ann Allergy Asthma Immunol 2003 90 Suppl 7-12
3. Quraishi SA Davies MJ Craig TJ Inflammatory responses in allergic rhinitis: Traditional approaches and novel treatment strategies J Am Osteopath Assoc 2004 104 5 Suppl 5 S7-S15 15176523
4. Bousquet J Van Cauwenberge P Khaltaev N Allergic rhinitis and its impact on asthma J Allergy Clin Immunol 2001 108 Suppl 5 S147-S334
5. Bousquet J Jacquot W Vignola AM Bachert C Van Cauwenberge P Allergic rhinitis: A disease remodeling the upper airways? J Allergy Clin Immunol 2004 113 43-49 14713906
6. Bloebaum R Managing allergic rhinitis: The role of pharmacotherapy; sound treatment can improve your patient's quality of life J Respir Dis 2002 23 370-376
7. Gelfand EW Inflammatory mediators in allergic rhinitis J Allergy Clin Immunol 2004 114 S135-S138 15536444
8. Storms WW Pharmacologic approaches to daytime and nighttime symptoms of allergic rhinitis J Allergy Clin Immunol 2004 114 S146-S153 15536446
9. Stoeck M Riedel R Hochhaus G Häfner D Masso JM Schmidt B Hatzelmann A Marx D Bundschuh DS In vitro and in vivo anti-inflammatory activity of the new glucocorticoid ciclesonide J Pharmacol Exp Ther 2004 309 249-258 14718604
10. Mealy NE Bayès M Castañer J Ciclesonide: Treatment of allergic rhinitis antiallergy/antiasthmatic Drugs Future 2001 26 1033-1039
11. Schmidt B Timmer W Georgens AC Hilt M Mattinger C Wurst W Hormann K Wehling M The new topical steroid ciclesonide is effective in the treatment of allergic rhinitis J Clin Pharmacol 1999 39 1062-1069 10516941
12. Dietzel K Engelstätter R Keller A Ciclesonide: An on-site-activated steroid New Drugs for Asthma, Allergy and COPD. Progress in Respiratory Research Basel, Switzerland: Karger Hansel TT, Barnes PJ 2001 31 91-93
13. Nave R Meyer W Fuhst R Zech Z Formation of fatty acid conjugates of ciclesonide active metabolite in the rat lung after 4-week inhalation of ciclesonide Pulm Pharmacol Ther 2005 18 390-396 16179214
14. Mutch E Nave R Zech K Williams FM Esterases involved in the hydrolysis of ciclesonide in human tissues [abstract] Eur Respir J 2003 22 Suppl 45 267s-268s
15. Petersen H Kullberg A Edsbacker S Greiff L Nasal retention of budesonide and fluticasone in man: Formation of airway mucosal budesonide-esters in vivo Br J Clin Pharmacol 2001 51 159-163 11259988
16. Stanaland BE Once-daily budesonide aqueous nasal spray for allergic rhinitis: Review Clin Ther 2004 26 473-492 15189745
17. Dykewicz MS Kaiser HB Nathan RA Goode-Sellers S Cook CK Witham LA Philpot EE Rickard K Fluticasone propionate aqueous nasal spray improves nasal symptoms of seasonal allergic rhinitis when used as needed (prn) Ann Allergy Asthma Immunol 2003 91 44-48 12877448
18. Szefler SJ Pharmacokinetics of intranasal corticosteroids J Allergy Clin Immunol 2001 108 Suppl S26-S31
19. Wingertzahn MA Sato H Nave R Nonaka T Mochizuki S Takahama S Comparison of nasal tissue concentrations in rabbits following administration of hypotonic and isotonic ciclesonide suspensions [abstract] J Allergy Clin Immunol 2005 115 Suppl S126
20. Naclerio RM Baroody FM Bidani N De Tineo M Penney BC A comparison of nasal clearance after treatment of perennial allergic rhinitis with budesonide and mometasone Otolaryngol Head Neck Surg 2003 128 220-227 12601318
21. Marple B Roland P Benninger M Safety review of benzalkonium chloride used as a preservative in intranasal solutions: An overview of conflicting data and opinions Otolaryngol Head Neck Surg 2004 130 131-141 14726922
22. Lebe E Baka M Yavasoglu A Aktug H Ates U Uyanikgil Y Effects of preservatives in nasal formulations on the mucosal integrity: An electron microscopic study Pharmacology 2004 72 113-120 15331917
23. Esmailpour N Hogger P Rohdewald P Binding of glucocorticoids to human nasal tissue in vitro Int Arch Allergy Immunol 2000 122 151-154 10878494
24. Bonsmann U Bachert C Delank KW Rohdewald P Presence of fluticasone propionate on human nasal mucosal surface and in human nasal tissue over a period of 24 h after intranasal application Allergy 2001 56 532-535 11421898
25. Yu S Zhao Y Wu F Zhang X Lu W Zhang H Zhang Q Nasal insulin delivery in the chitosan solution: In vitro and in vivo studies Int J Pharm 2004 281 11-23 15288339
26. Dua R Zia H Needham T The influence of tonicity and viscosity on the intranasal absorption of salmon calcitonin in rabbits Int J Pharm 1997 147 233-242
27. Nishinaka D Kishino F Matsuura A Water and electrolyte absorption from hypotonic oral rehydration solution in rat small intestine and colon Pediatr Int 2004 46 315-321 15151549
28. Wapnir RA Lifshitz F Osmolality and solute concentration - their relationship with oral hydration solution effectiveness: An experimental assessment Pediatr Res 1985 19 894-898 4047757
29. Wingertzahn MA Sato H Nave R Nonaka T Mochizuki T Takahama S Kondo S Esterases involved in the metabolism of ciclesonide (CIC) in human nasal epithelial cells (HNEC) [abstract] J Allergy Clin Immunol 2006 117 S167
30. Nave R Fisher R Zech K In vitro metabolism of ciclesonide in human lung and liver precision-cut tissue slices Biopharm Drug Dispos 2006 27 4 197-207 16566061
31. Tunek A Sjödin K Hallström G Reversible formation of fatty acid esters of budesonide, an antiasthma glucocorticoid, in human lung and liver microsomes Drug Metab Dispos 1997 25 1311-1317 9351909
32. Nave R Hummel RP Wohlsen A Herzog R Zech K The active metabolite of ciclesonide, des-isobutyryl ciclesonide, forms highly lipophilic fatty acid conjugates in precision-cut rat lung slices [abstract] Am J Respir Crit Care Med 2004 169 Suppl A91